These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26613267)

  • 1. The potential of the novel leukocyte removal filter in cardiopulmonary bypass.
    Fujii Y
    Expert Rev Med Devices; 2016; 13(1):5-14. PubMed ID: 26613267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review.
    Boodram S; Evans E
    J Extra Corpor Technol; 2008 Mar; 40(1):27-42. PubMed ID: 18389663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of leukocyte depletion filter-LD-1 on leukocytes, IL-6, MPO and the pathologic changes of myocardic tissues during cardiopulmonary bypass].
    Zhu ZQ; Yang YB; Zheng H; Du L; Deng SZ; Liu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):429-31. PubMed ID: 15931888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass.
    Ilmakunnas M; Pesonen EJ; Ahonen J; Rämö J; Siitonen S; Repo H
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):851-9. PubMed ID: 15821654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of various leukocyte filtration strategies in cardiac surgery.
    Warren O; Alexiou C; Massey R; Leff D; Purkayastha S; Kinross J; Darzi A; Athanasiou T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):665-76. PubMed ID: 17240156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte depletion during cardiopulmonary bypass in routine adult cardiac surgery.
    Bechtel JF; Mühlenbein S; Eichler W; Marx M; Sievers HH
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):207-12. PubMed ID: 21051377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass.
    Chen YF; Tsai WC; Lin CC; Tsai LY; Lee CS; Huang CH; Pan PC; Chen ML
    Ann Thorac Surg; 2004 Aug; 78(2):634-42; discussion 642-3. PubMed ID: 15276536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pulmonary protective effects of leukocyte depletion with a modified filter located at the cardiopulmonary bypass (CPB) venous line in canine].
    Li Q; Chen HJ; Du L; Zhou L; Wang Y; Liu B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):723-6. PubMed ID: 16235549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial.
    Leal-Noval SR; Amaya R; Herruzo A; Hernández A; Ordóñez A; Marín-Niebla A; Camacho P
    Ann Thorac Surg; 2005 Oct; 80(4):1394-400. PubMed ID: 16181877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammatory response syndrome is reduced by preoperative plasma-thrombo-leukocyte aphaeresis in a pig model of cardiopulmonary bypass.
    Wagner R; Piler P; Uchytil B; Halouzka R; Kovaru H; Bobkova M; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):399-406. PubMed ID: 27049532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Leukocyte Modulator Device Reduces the Inflammatory Response to Cardiopulmonary Bypass.
    Johnston KA; Westover AJ; Rojas-Pena A; Haft JW; Toomasian JM; Johnson T; Buffington DA; Humes HD
    ASAIO J; 2019; 65(4):401-407. PubMed ID: 29863627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement.
    Sutton SW; Patel AN; Chase VA; Schmidt LA; Hunley EK; Yancey LW; Hebeler RF; Cheung EH; Henry AC; Meyers TP; Wood RE
    Perfusion; 2005 Jan; 20(1):21-9. PubMed ID: 15751667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of leukocyte depletion filter on canine kidney during cardiopulmonary bypass].
    Yang YB; Zhu ZQ; Zheng H; Du L; Huang SM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):321-4. PubMed ID: 16045024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery.
    Koskenkari J; Rimpiläinen J; Biancari F; Surcel HM; Kaukoranta P; Kiviluoma K; Ala-Kokko T; Juvonen T
    Scand Cardiovasc J; 2005 Dec; 39(6):358-68. PubMed ID: 16352489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease.
    Karaiskos TE; Palatianos GM; Triantafillou CD; Kantidakis GH; Astras GM; Papadakis EG; Vassili MI
    Ann Thorac Surg; 2004 Oct; 78(4):1339-44. PubMed ID: 15464496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
    Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
    Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of two-phase leukocyte filtration in high-risk patients undergoing coronary revascularization with cardiopulmonary bypass.
    Gunaydin S; Modine T; Sari T; Zorlutuna Y; Gourlay T
    J Extra Corpor Technol; 2009 Sep; 41(3):149-56. PubMed ID: 19806797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory response to CPB: the role of leukocyte filtration.
    Asimakopoulos G
    Perfusion; 2002 May; 17 Suppl():7-10. PubMed ID: 12009089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.
    Apostolakis EE; Koletsis EN; Baikoussis NG; Siminelakis SN; Papadopoulos GS
    J Cardiothorac Surg; 2010 Jan; 5():1. PubMed ID: 20064238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of Cardiopulmonary Bypass: Current Strategies for the Prevention and Treatment of Anemia, Coagulopathy, and Organ Dysfunction.
    Esper SA; Subramaniam K; Tanaka KA
    Semin Cardiothorac Vasc Anesth; 2014 Jun; 18(2):161-76. PubMed ID: 24876231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.